Benzodiazepine

From Citizendium
Revision as of 11:34, 4 June 2010 by imported>Howard C. Berkowitz
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In pharmacology, benzodiazepines are a class of medications that are "a group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring."[1] All benzodiazepines affect specific benzodiazepine receptors and modulate gamma-aminobutyric acid. Specific benzodiazepines also affect other neurotransmitters (e.g., clonazepam and alprazolam affect serotonin). Receptor relationships are quite complex and are discussed further below.

Uses include the treatment of anxiety disorders and alcohol withdrawal syndrome. Some are used as anticonvulsants and to treat musculoskeletal spasticity.

Examples are:

  • Alprazolam
  • Benzodiazepinones
    • Anthramycin
    • Bromazepam
    • Clonazepam
    • Devazepide
    • Diazepam (Valium)
    • Flumazenil
    • Flunitrazepam
    • Flurazepam
    • Lorazepam
    • Nitrazepam
    • Oxazepam
    • Pirenzepine
    • Prazepam
    • Temazepam
  • Chlordiazepoxide (Librium)
  • Clorazepate dipotassium
  • Estazolam
  • Medazepam
  • Midazolam (Versed)
  • Triazolam

Receptors

Part of the confusion in the receptors they affect come from the observation that what had previously been considered the GABAA-benzodiazepine-Cl- channel complex receptor has numerous sub-receptors, in five classes (α, β, γ, δ, ρ) with at least 16 subtypes. Benzodiazepine receptor type 1, for example, involves binding to α1, β2 and γ2.[2] The interactions among GABA, benzodiazepines, and some other classes of drugs are even more complex, in that binding to one receptor type affects other receptors. For example, certain bindings to benzodiazepine receptors will increase the rate of opening of the GABAA receptor,[3] potentiating the effect of both endogenous GABA and GABA released by direct GABA agonists such as baclofen.

Clinical use

Anxiety

Convulsive disorders

Musculoskeletal spasticity

Toxicity and abuse

References

  1. Anonymous (2024), Benzodiazepine (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Ross J. Baldessarini (1996), Chapter 18, Drugs and the treatment of Psychiatric Disorders: Psychosis and Anxiety, in Joel G. Hardman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics (Ninth Edition ed.), McGraw-Hill, ISBN 0070262667 pp. 421-434
  3. Robin Mantooth (28 January 2010), Toxicity, Benzodiazepine, eMedicine